Crossmark

Dynamics of platelet activation in cold-stored low-titer group O whole blood over 8 days: insights relative to standard platelet concentrates

Crossref DOI link: https://doi.org/10.1186/s40635-026-00945-x

Published Online: 2026-07-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cognasse, Fabrice https://orcid.org/0000-0001-8041-928X
Desseux, Karine

Artero, Véronique

Duraffourg, Véronique

Arthaud, Charles-Antoine

Prier, Amélie

Eyraud, Marie-Ange

Maillot, Victorine

Crespe, Damien

Martinaud, Christophe

Ausset, Sylvain

Tiberghien, Pierre

Aoustin, Laurent

Chavarin, Patricia

Banzet, Sébastien

Frescaline, Nadira

Hamzeh-Cognasse, Hind
Funding

Funding for this research was provided by:

Etablissement Français du Sang (Etablissement Français du Sang)

the association Les Amis de Rémi (Savigneux), (the association Les Amis de Rémi (Savigneux),)

Agence Nationale de la Recherche (ANR-22-CE17-0063 (HEASY_PLAT))

Agence Nationale de la Recherche (ANR-23-ASTR-0012-01 (PEDESTAL).)
License Information

Text and Data Mining valid from 2026-07-13

Version of Record valid from 2026-07-13
More Information

Article History

Received: 16 April 2026

Accepted: 30 June 2026

First Online: 13 July 2026

Declarations

:

: The French Military Health Service will promote the T-STORHM clinical trial (ClinicalTrials.gov ID NCT04431999) in collaboration with the French Blood Establishment and six trauma centers across the country. The main military medical centers, as well as four civilian trauma centers, will participate in this study. Our work concerns an ancillary study of T-STORHM using an in vitro approach.

: All authors have read and approved the final version of the manuscript prior to submission and consent to its publication.

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below